Enteromedics' Maestro weight loss device squeezes through US regulatory hoop
This article was originally published in Clinica
Executive Summary
It has been a tumultuous path to approval, but Enteromedics’ Maestro treatment for obesity has finally got the US FDA go-ahead, in spite of doubts over its efficacy. The device intermittently blocks the vagus nerve to influence perceptions of hunger and fullness.